Another notable example is hsa-miR-574–5p which promotes metastasis in NSCLC by targeting PCP2 in tumor tissues (Zhou et al., 2016) and has been proposed as an early stage NSCLC serum biomarker (Foss et al., 2011). This evidence concerns the gene PCP2 and non-small cell lung carcinoma.